Company
Headquarters: Toronto, ON, Canada
CEO: Mr. Gregory Edward Wagner
No stock data available
Company | Market Cap (USD) |
---|---|
Veeva Systems Inc. | $46.46 B |
GE HealthCare | $34.85 B |
Change Healthcare Inc. | $9.03 B |
M3, Inc. | $8.98 B |
Pro Medicus Limited | $8.96 B |
Company | Market Cap (USD) |
---|---|
Lilly | $699.59 B |
Johnson & Johnson | $374.29 B |
AbbVie | $336.94 B |
Novo Nordisk | $309.91 B |
UnitedHealth Group | $279.90 B |
RYAH Group, Inc., a big data and technology company, develops various Internet of Things products. It offers dose-control devices, such as RYAH Smart Patch that provides users with the ability to boost their patch for on-demand relief; RYAH Smart Inhaler, a dry herb inhaler with an integrated volumetric airflow sensor, which enable consumers to track and control how much they inhale; and RYAH Smart Pen, a multi-liquid chamber pen that dispense up to three different formulations at once for a dose controlled entourage effect. The company also provides RYAH MD, a platform for doctors to remotely monitor and control their patients' dosing regimen with RYAH's suite of dose-measuring products; and RYAH Cloud, a data engine that captures millions of points of structured and unstructured data, and analyze seed-to-consumer intelligence to enable doctors and clinics to create personalized therapies. RYAH Group, Inc. has a collaboration with the University of Milan, Italy. RYAH Group, Inc. is based in Toronto, Canada.
Ryah Group, Inc. has the following listings and related stock indices.
Stock: CSE: RYAH wb_incandescent